Bank of Montreal’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,845
| Closed | -$27K | – | 4078 |
|
|
2022
Q1 | $27K | Buy |
+1,845
| New | +$52.5K | ﹤0.01% | 3886 |
|
|
2021
Q4 | – | Sell |
-10,859
| Closed | -$693K | – | 3499 |
|
|
2021
Q3 | $693K | Buy |
+10,859
| New | +$708K | ﹤0.01% | 2686 |
|
|
2021
Q2 | – | Sell |
-111
| Closed | -$10K | – | 3742 |
|
|
2021
Q1 | $10K | Sell |
111
-1,232
| -92% | -$125K | ﹤0.01% | 4359 |
|
|
2020
Q4 | $117K | Buy |
1,343
+350
| +35% | +$31.3K | ﹤0.01% | 3496 |
|
|
2020
Q3 | $107K | Buy |
993
+550
| +124% | +$76.4K | ﹤0.01% | 3036 |
|
|
2020
Q2 | $73K | Buy |
+443
| New | +$43.7K | ﹤0.01% | 3237 |
|
|
2020
Q1 | – | Sell |
-1,586
| Closed | -$269K | – | 4100 |
|
|
2019
Q4 | $269K | Sell |
1,586
-5,124
| -76% | -$846K | ﹤0.01% | 2997 |
|
|
2019
Q3 | $1.25M | Buy |
6,710
+5,482
| +446% | +$1.06M | ﹤0.01% | 1970 |
|
|
2019
Q2 | $281K | Buy |
1,228
+718
| +141% | +$140K | ﹤0.01% | 2742 |
|
|
2019
Q1 | $107K | Sell |
510
-456
| -47% | -$85.5K | ﹤0.01% | 3024 |
|
|
2018
Q4 | $111K | Buy |
966
+896
| +1,280% | +$133K | ﹤0.01% | 2898 |
|
|
2018
Q3 | $16K | Sell |
70
-2,091
| -97% | -$462K | ﹤0.01% | 3771 |
|
|
2018
Q2 | $481K | Sell |
2,161
-5,051
| -70% | -$1.13M | ﹤0.01% | 2354 |
|
|
2018
Q1 | $1.65M | Buy |
7,212
+3,300
| +84% | +$867K | ﹤0.01% | 1652 |
|
|
2017
Q4 | $1.02M | Buy |
3,912
+3,879
| +11,755% | +$909K | ﹤0.01% | 1940 |
|
|
2017
Q3 | $7K | Hold |
33
| – | – | ﹤0.01% | 3799 |
|
|
2017
Q2 | $9K | Hold |
33
| – | – | ﹤0.01% | 3734 |
|
|
2017
Q1 | $8K | Sell |
33
-550
| -94% | -$126K | ﹤0.01% | 3600 |
|
|
2016
Q4 | $145K | Buy |
583
+33
| +6% | +$7.84K | ﹤0.01% | 2655 |
|
|
2016
Q3 | $150K | Buy |
550
+450
| +450% | +$99.6K | ﹤0.01% | 2569 |
|
|
2016
Q2 | $14K | Sell |
100
-14
| -12% | -$1.88K | ﹤0.01% | 3484 |
|
|
2016
Q1 | $16K | Buy |
114
+82
| +256% | +$11.6K | ﹤0.01% | 3469 |
|
|
2015
Q4 | $7K | Buy |
32
+18
| +129% | +$3.29K | ﹤0.01% | 3690 |
|
|
2015
Q3 | $2K | Hold |
14
| – | – | ﹤0.01% | 3783 |
|
|
2015
Q2 | $4K | Hold |
14
| – | – | ﹤0.01% | 3649 |
|
|
2015
Q1 | $3K | Hold |
14
| – | – | ﹤0.01% | 3705 |
|
|
2014
Q4 | $3K | Buy |
+14
| New | +$3K | ﹤0.01% | 3769 |
|
|
2014
Q3 | – | Sell |
-28
| Closed | -$7K | – | 4023 |
|
|
2014
Q2 | $7K | Buy |
+28
| New | +$6.11K | ﹤0.01% | 3998 |
|
Other funds holding AXDX
GAM
OIM
BC
CC
CIA
BAM
Bank of Montreal's AXDX Position: Q2 2022 in Review
Bank of Montreal sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,845 shares — an estimated $27K sold.
Bank of Montreal first reported a position in AXDX in Q2 2014 and held it in 28 quarters. The position peaked at $1.65M in Q1 2018. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.
- Bank of Montreal reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
- Bank of Montreal sold 1,845 Accelerate Diagnostics shares in Q2 2022, an estimated $27K.
- Bank of Montreal first reported a position in Accelerate Diagnostics in Q2 2014 and held it in 28 quarters.
- Bank of Montreal's Accelerate Diagnostics position peaked at $1.65M in Q1 2018.
- 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.
Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.